Answers are grounded in this paper and cite their sources.
Bronchial asthma is an inflammatory lung disease, which is a fairly common non-infectious chronic disease in childhood. The so-called gap junction proteins, connexins and pannexins (Px), play an important role in the processes of sensitization formation and maintenance of chronic inflammation in the bronchi. Therefore, the study of Px indices in patients with bronchial asthma is of scientific and practical interest. Objective. To analyze Px1 indices in the blood serum of children with BA. Materials and methods. A single-center prospective continuous controlled study was conducted on 125 patients with an established diagnosis of BA and 30 patients of health groups I and IIa included in the control group. All children underwent a comprehensive clinical and laboratory examination. Quantitative determination of the Px1 level in the blood serum was carried out using enzyme-linked immunosorbent assay (ELISA) using the SEE788Hu kit (Cloud-Clone. Corporation, Wuhan, China). Statistical processing of the obtained data was carried out using the Statistica 12.0 for Windows software package. Results. It was found that the average Px1 values in the blood serum of children with an established diagnosis of bronchial asthma (0.20 [0.17; 0.26] ng / ml) exceeded the values in the control group (0.16 [0.14; 0.17]) [ p = 0.014]. At the same time, the concentration of Px1 in patients with varying severity of the disease does not have reliable differences ( p = 0.122). A direct relationship was established between the increase in the concentration of Px1 in the blood serum of patients and the increase in the respiratory rate ( r = 0.36) and an inverse relationship between the Px1 values in the blood serum of patients and the peak expiratory flow values ( r = -0.23). Conclusion. Px1 is a significant factor in the pathogenesis of bronchial asthma. Activation of this protein during an exacerbation of the disease can be accompanied by the release of a significant amount of adenosine triphosphate, which leads to the attraction of immune cells to the site of inflammation and activation, as well as increased broncho-obstruction. Given these circumstances, an increase in the level of Px1 in the blood serum of patients may be evidence of a violation of the regulation of the ATP release mechanism in chronic inflammation and a marker of the activity of the process in patients with bronchial asthma.
No takes yet. Share an insight, caveat, or question.
Евгеньевна et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: